Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Immunohistochemical Expression of Bcl2 is an Independent Predictor of Time-to-biochemical Failure in Patients with Clinically Localized Prostate Cancer Following Radical Prostatectomy

KYRIAKOS REVELOS, CONSTANTINA PETRAKI, ALKIVIADIS GREGORAKIS, ANDREAS SCORILAS, PANAGIOTIS PAPANASTASIOU and MICHAEL KOUTSILIERIS
Anticancer Research July 2005, 25 (4) 3123-3133;
KYRIAKOS REVELOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CONSTANTINA PETRAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALKIVIADIS GREGORAKIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREAS SCORILAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PANAGIOTIS PAPANASTASIOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAEL KOUTSILIERIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mkouts@medscape.com
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Whether the immunohistochemical expression (IHCE) of the bcl2, the p53 and of the prostate apoptosis response-4 (PAR4) proteins is associated with preoperative PSA levels, post-operative parameters of prostate cancer (PC) pathology, surgical staging or biochemical failure (BF) of patients with clinically localized PC who underwent radical prostatectomy (RP) of curative intent, was investigated. Patients and Methods: A retrospective analysis of clinical data evaluating surgical specimens of 131 patients with PC, consecutively treated with RP for clinically localized disease, was performed. The IHC method of streptavidin biotin peroxidase on paraffin tissue sections was used to detect bcl2 and p53 oncoproteins and PAR4 pro-apoptotic protein expression in surgical specimens. Results: Statistically significant relationships were detected between: (i) p53 IHC expression and infiltration of periprostatic tissue (IPT; p=0.011); (ii) tumor volume (TV; p=0.027); and (iii) bcl2 IHCE and absence of prostatic intraepithelial neoplasia (PIN) (p=0.004). Biochemical failure (BF) was documented in 37% of these patients. Kaplan-Meier survival curves showed that the IHCE of bcl2 and p53 was significantly related to BF. Taking the hazard ratio (HR) estimated from the Cox proportional hazard regression model to be 1.00 for patients with negative bcl2 IHCE, a value of 2.82 was found for patients with positive bcl2 IHCE (p=0.015, 95% CI=1.22-6.47). The HR for patients with positive p53 IHCE was 2.05 (p=0.048, 95% CI=1.00-4.19). Multivariate analysis showed that only seminal vesicle invasion (SVI), pelvic lymph node metastasis (PLNM) and bcl2 IHCE were independent predictors for BF (HR=3.06, 3.31 and 3.15; p=0.048, p=0.031 and p=0.031 for SVI, PLNM and bcl2 IHCE, respectively). Conclusion: Bcl2 immunohistochemical overexpression in specimens of RP suggests high risk for BF in clinically localized PC.

  • Clinically localized prostate cancer
  • bcl2
  • p53
  • PAR4
  • biochemical failure

Footnotes

  • Received January 20, 2005.
  • Accepted April 12, 2005.
  • Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 25 (4)
Anticancer Research
Vol. 25, Issue 4
1 Jul 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Immunohistochemical Expression of Bcl2 is an Independent Predictor of Time-to-biochemical Failure in Patients with Clinically Localized Prostate Cancer Following Radical Prostatectomy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Immunohistochemical Expression of Bcl2 is an Independent Predictor of Time-to-biochemical Failure in Patients with Clinically Localized Prostate Cancer Following Radical Prostatectomy
KYRIAKOS REVELOS, CONSTANTINA PETRAKI, ALKIVIADIS GREGORAKIS, ANDREAS SCORILAS, PANAGIOTIS PAPANASTASIOU, MICHAEL KOUTSILIERIS
Anticancer Research Jul 2005, 25 (4) 3123-3133;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Immunohistochemical Expression of Bcl2 is an Independent Predictor of Time-to-biochemical Failure in Patients with Clinically Localized Prostate Cancer Following Radical Prostatectomy
KYRIAKOS REVELOS, CONSTANTINA PETRAKI, ALKIVIADIS GREGORAKIS, ANDREAS SCORILAS, PANAGIOTIS PAPANASTASIOU, MICHAEL KOUTSILIERIS
Anticancer Research Jul 2005, 25 (4) 3123-3133;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Prediction of Prostate Cancer Recurrence Using Magnetic Resonance Imaging and Molecular Profiles
  • A Dietary Anthocyanidin Delphinidin Induces Apoptosis of Human Prostate Cancer PC3 Cells In vitro and In vivo: Involvement of Nuclear Factor-{kappa}B Signaling
  • Google Scholar

More in this TOC Section

  • Impact of Surgery Refusal on Overall Survival in Merkel Cell Carcinoma
  • Association of County-level Social Determinants and Pancreatic Cancer Incidence in the United States
  • Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire